Abstract
The authors regret that the upper IQR values reported in Table 1 for the baseline age and hsCRP were wrong for the Vortioxetine + Placebo group and for the Vortioxetine + Celecoxib group. Table 1 has been updated with the correct values. The authors would like to apologise for any inconvenience caused.
Original language | English |
---|---|
Pages (from-to) | 61-62 |
Number of pages | 2 |
Journal | European Neuropsychopharmacology |
Volume | 64 |
DOIs |
|
Publication status | Published or Issued - Nov 2022 |
Externally published | Yes |
ASJC Scopus subject areas
- Pharmacology
- Neurology
- Clinical Neurology
- Psychiatry and Mental health
- Biological Psychiatry
- Pharmacology (medical)